[1] Boerman OC, Dams ETM, Oyen WJG, et al. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation[J]. Inflamm Res, 2001, 50:55-64.
[2] Ercan MT, Unlenen E. Accumulation of some small molecular weight complexes of 99Tcm in experimental abscesses[J]. Nucl Med Biol, 1994, 21(2):143-149.
[3] Datz FL. Abdominal abscess detection:gallium, 111In, and 99Tcm-labelled leukocytes, and polyclonal and monoclonal antibodies[J]. Semin Nucl Med, 1996, 26(1):51-64.
[4] Rennen HJJM, Boerman OC, Oyen WJG, et al. Imaging infection/inflammation in the new millennium[J]. Eur J Nucl Med, 2001, 28(2):241-252.
[5] Babich JW, Graham W, Barrow SA, et al. Technetium-99m-labelled chemotactic peptide:comparison with indium-111-labelled white blood cells for localizing acute bacterial infection in the rabbit[J]. J Nucl Med, 1993, 34:2176-2181.
[6] Pollak A, Goodbody AE, Ballinger JR, et al. Imaging inflammation with 99Tcm-labelled chemotactic peptides:analogues with reduced neutropenia[J]. Nucl Med Commun,1996, 17:132-139.
[7] Rusckowski M, Qu T, Pullman J, et al. Inflammation and infection imaging with a 99Tcm-neutrophil elastase inhibitor in monkeys[J]. J Nucl Med, 2000, 41:363-374.
[8] Caveliers V, Goodbody AE, Tran LL, et al. Evaluation of 99Tcm-RP128 as a potential inflammation imaging agent:human dosimetry and first clinical results[J]. J Nucl Med, 2001, 42:154-161.
[9] Babich JW, Tompkins RG, Graham W, et al. Localization of radiolabeled chemotactic peptide at focal sites of Escherichia coli infection in rabbits:evidence for a receptorspecific mechanism[J]. J Nucl Med, 1997, 38:1316-1322.
[10] van der Laken CJ, Boerman OC, Oyen WJG, et al. Imaging of infection in rabbits with radioiodinated interleukin-1(α and β), its receptor antagonist and a chemotactic peptide:a comparative study[J]. Eur J Nucl Med, 1998, 25(4):347-352.
[11] Chianelli M, Signore A, Fritzberg AR, et al. The development of technetium-99m-labelled interleukin-2:a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases[J]. Nucl Med Biol, 1997, 24:579-586.
[12] Rennen HJJM, Boerman OC, Oyen WJG, et al. Specific and rapid scintigraphic detection of infection with 99Tcm-labelled interleukin-8[J]. J Nucl Med, 2001, 42:117-123.
[13] Moyer BR, Vallabhajosula S, Lister-James J, et al. Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection[J]. J Nucl Med, 1996, 37:673-679.
[14] Britton KE, Vinjamuri S, Hall AV, et al. Clinical evaluation of technetium-99m infection for the localisation of bacterial infection[J]. Eur J Nucl Med, 1997, 24(5):553-556.